Department of Gastroenterology, Zhejiang Provincial Clinical Research Center for Digestive Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Gastroenterology, Zhejiang Provincial Clinical Research Center for Digestive Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Cell Mol Gastroenterol Hepatol. 2024;17(2):251-265. doi: 10.1016/j.jcmgh.2023.10.005. Epub 2023 Oct 24.
BACKGROUND & AIMS: Acetaminophen (APAP) overdose is the most common cause of drug-induced liver injury worldwide. Uric acid (UA) is involved in sterile inflammation in many organs, but its role in APAP-induced liver injury remains elusive.
We quantified the concentration of UA in the serum and liver tissues of APAP-overdosed mice and explored the changes in proteins involved in UA synthesis, absorption, and degeneration on APAP stimulation. We also examined the effects of inhibiting hepatocyte UA synthesis or reabsorption on APAP-induced liver injury in mice. Furthermore, we explored the process of UA clearance by peripheral macrophages.
APAP overdose significantly increased intrahepatic UA contents, which occurred earlier than apparent hepatocyte injury in APAP-overdosed mice. APAP overdose induced significant DNA leakage and may thereby increase the substrate of UA synthesis. APAP overdose also significantly increased the enzymatic activity of xanthine oxidase and urate oxidase and decreased the expression of the UA reabsorption transporter GLUT9 in hepatocytes. Inhibiting hepatocyte UA synthesis by febuxostat or reabsorption by hepatic-specific knockout of GLUT9 alleviated APAP-induced liver injury. Further experiments showed that monosodium urate but not soluble UA may be a major form of UA mediating hepatocyte injury. Additionally, monosodium urate further recruited circulating macrophages into the liver and then aggravated inflammation by increasing the levels of inflammatory factors and reactive oxygen species. Deletion of macrophages significantly ameliorated APAP-induced liver injury in mice.
APAP overdose induces excessive UA production and leads to local high concentrations in the liver, which further injures cells and induces liver inflammation. Inhibiting the production of UA may be a potential therapeutic option for treating APAP-induced liver injury.
对乙酰氨基酚(APAP)过量是全世界导致药物性肝损伤的最常见原因。尿酸(UA)参与许多器官的无菌性炎症,但它在 APAP 诱导的肝损伤中的作用仍不清楚。
我们定量检测了 APAP 过量小鼠血清和肝组织中 UA 的浓度,并探讨了 APAP 刺激下与 UA 合成、吸收和降解相关的蛋白的变化。我们还研究了抑制肝细胞 UA 合成或重吸收对 APAP 诱导的肝损伤的影响。此外,我们还探索了外周巨噬细胞清除 UA 的过程。
APAP 过量显著增加了肝内 UA 含量,这比 APAP 过量小鼠中明显的肝细胞损伤更早发生。APAP 过量诱导明显的 DNA 漏出,从而可能增加 UA 合成的底物。APAP 过量还显著增加了黄嘌呤氧化酶和尿酸氧化酶的酶活性,并降低了肝细胞中 UA 重吸收转运蛋白 GLUT9 的表达。通过别嘌醇抑制肝细胞 UA 合成或通过肝特异性 GLUT9 敲除抑制重吸收均可减轻 APAP 诱导的肝损伤。进一步的实验表明,单尿酸钠而不是可溶性 UA 可能是介导肝细胞损伤的 UA 的主要形式。此外,单尿酸钠进一步招募循环巨噬细胞进入肝脏,并通过增加炎症因子和活性氧的水平加重炎症。巨噬细胞缺失显著改善了 APAP 诱导的小鼠肝损伤。
APAP 过量诱导 UA 产生过多,并导致肝脏局部 UA 浓度升高,从而进一步损伤细胞并诱导肝炎症。抑制 UA 的产生可能是治疗 APAP 诱导的肝损伤的一种潜在治疗选择。